Compare
5 stocks, side by sideRelative performance · rebased to 100
LXRXKYMRNRIXSLSZBIO
| LXRXLexicon Pharmaceuticals, Inc. | KYMRKymera Therapeutics, Inc. | NRIXNurix Therapeutics, Inc. | SLSSELLAS Life Sciences Group, Inc. | ZBIOZenas BioPharma, Inc. | |
|---|---|---|---|---|---|
| Smart Score | 10/10 | 10/10 | 7/10 | 10/10 | 4/10 |
| Price | $2.29 | $116.46 | $22.46 | $10.53 | $24.67 |
| 1 month | +11% | +44% | +29% | +30% | +32% |
| 1 year | +197% | +147% | +88% | +495% | +146% |
| 5 year | -52% | +144% | -24% | -8.1% | - |
| P/E (TTM) | -39.0 | -30.4 | -7.9 | -70.3 | -3.7 |
| P/E vs sector | - | - | - | - | - |
| Market cap | $1.0B | $9.6B | $2.3B | $2.1B | $1.6B |
| Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.